News | May 08, 2025
Suven Pharmaceuticals is now Cohance Lifesciences
The change of name has been carried on pursuant to the Scheme of Amalgamation
The change of name has been carried on pursuant to the Scheme of Amalgamation
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
Topiramate is indicated as a treatment of epilepsy and migraine
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Investment demonstrates confidence in America’s commitment to science and innovation
Subscribe To Our Newsletter & Stay Updated
